Home Biosciences

The first and leading biotech venture builder in Europe

Home Biosciences was founded in 2019, is headquartered in Paris, France, lists 11–50 employees, and has $15.0M in recorded funding across 1 round.

Headquarters
Paris
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M SeedAug 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Home Biosciences was a Paris-based biotech venture builder founded in 2019 by David Schilansky and Dr. Magali Richard, backed by Redmile Group and Sofinnova Partners. The company pioneered a hub-and-spoke asset-centric operating model in Continental Europe, partnering with leading academic scientists to identify ground-breaking research, then assembling dedicated execution teams and providing funding and operational infrastructure to co-found and scale independent biotech companies. Over five years, Home Biosciences co-founded three portfolio companies: One Biosciences (single-cell molecular profiling for oncology), Sequantrix (anti-fibrotic drug discovery), and Apikal Therapeutics. The company closed a $15 million seed financing round in 2021. Home Biosciences ended day-to-day operations in January 2025 and transitioned to a non-operating holding mode focused on building value for its portfolio companies.

Summary

Home Biosciences is a Biotech company based in Paris, France, founded in 2019. It lists 11–50 employees. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Aug 2021. Investors include Redmile Group and Sofinnova Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundAug 2021
$15.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Home Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/home-biosciences"><img src="https://indexed.vc/api/badge/company/home-biosciences" alt="Home Biosciences on Indexed.vc" width="260" height="76" /></a>